placeholder

Press Releases

All Releases
View Summary /C O R R E C T I O N -- Insmed Inc./
May 8, 2008
PDF 33.1 KB
View Summary Insmed Announces First Quarter 2008 Financial Results
May 8, 2008
PDF 19.5 KB
View Summary Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
Apr 29, 2008
PDF 22.9 KB
View Summary Insmed to Host First Quarter 2008 Conference Call
Apr 24, 2008
PDF 18.5 KB
View Summary Insmed to Present at CBI Follow-On Biologics Conference
Apr 22, 2008
PDF 18.0 KB
View Summary Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
Apr 16, 2008
PDF 19.3 KB
View Summary Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
Apr 10, 2008
PDF 18.9 KB
View Summary Insmed Announces Additional Information in Compliance With NASDAQ Rules
Mar 18, 2008
PDF 16.4 KB
View Summary Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
Mar 4, 2008
PDF 30.0 KB
View Summary Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
Feb 28, 2008
PDF 18.4 KB
View Summary Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
Feb 19, 2008
PDF 18.8 KB
View Summary Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics
Feb 11, 2008
PDF 21.9 KB
View Summary Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
Feb 5, 2008
PDF 18.9 KB
View Summary Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
Feb 5, 2008
PDF 18.2 KB
View Summary Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
Jan 24, 2008
PDF 19.7 KB
View Summary Insmed Completes External Assessment of Myotonic Muscular Dystrophy Market
Jan 22, 2008
PDF 18.7 KB
View Summary Insmed to Appeal Delisting Notification From Nasdaq
Dec 26, 2007
PDF 16.6 KB
View Summary Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
Dec 18, 2007
PDF 19.1 KB
View Summary Insmed Awarded $2.1 Million by Muscular Dystrophy Association
Dec 12, 2007
PDF 18.9 KB
View Summary Insmed Appoints Dennis M. Lanfear to Board Of Directors
Dec 6, 2007
PDF 18.9 KB
Showing 1-20 of 222 Page: 1 2 3 ... 12  Next 20

Press Releases

  • May 8, 2008
    Insmed Announces First Quarter 2008 Financial Results Read More
  • May 8, 2008
    /C O R R E C T I O N -- Insmed Inc./ Read More